Maria Dorobantu

TL;DR: The global repositioning of lipid-related risk, with non-optimal cholesterol shifting from a distinct feature of high-income countries in northwestern Europe, north America and Australasia to one that affects countries in east and southeast Asia and Oceania should motivate the use of population-based policies and personal interventions to improve nutrition and enhance access to treatment throughout the world.

TL;DR: In this article, the authors investigated how much change in mean body mass index (BMI) explains changes in the prevalence of underweight, obesity, and severe obesity in different regions using data from 2896 population-based studies with 187 million participants.

TL;DR: The proportion of adults with diabetes in LMICs who receive coverage of recommended pharmacological and non-pharmacological diabetes treatment and country-level and individual-level characteristics that are associated with treatment are estimated to be fewer than one in ten.

TL;DR: In this article, the authors summarize the current knowledge of cardiovascular injury and post-acute sequelae of COVID-19 and identify new biomarkers of cardiovascular complications, and development of effective treatments for COVID19 infection.

TL;DR: increasing age, inotrope therapy, the presence of life-threatening ventricular arrhythmias, and elevated baseline blood urea nitrogen were all found to be independent risk factors for in-hospital all-cause mortality, whereas elevated systolic blood pressure and baseline treatment with a β-blocker had a protective effect.